The Role of Immune Cells in the Tumor Microenvironment
Interactions between tumor infiltrating leukocytes and tumor cells have been of great interest because of the possibility that immune cells either interfere with tumor progression or actively promote tumor growth. The tumor microenvironment is shaped by cells entering it, and their functions reflect the local conditions. Successive changes occurring at the tumor site during tumor progression resemble chronic inflammation. This chronic inflammatory reaction seems to be largely orchestrated by the tumor, and it seems to promote tumor survival. Molecular and cellular mechanisms linking the inflammatory reaction and cancer are emerging, and this review summarizes the current understanding of interactions between inflammatory and cancer cells in the tumor microenvironment.
KeywordsTIL immune evasion immune surveillance inflammation cancer
Unable to display preview. Download preview PDF.
- Albers, A.E. et al. (2005). Immune response to p53 in patients with cancer: enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites. Cancer Immunol, Immunother. in press.Google Scholar
- Albers, A.E. et al. (2005). T-cell receptor variable gene β-restricted T lymphocytes are sensitive to apoptosis in patients with squamous cell carcinoma of the head and neck. Submitted.Google Scholar
- Aller, M.A. et al. (2004). Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune and endocrine function systems. Exp. Biol. Med. 229: 170–181.Google Scholar
- Gabrilovich, D. (2004). Mechanisms and functional significance of tumor-induced dendritic cell defects. Nature Med. 4: 941–952.Google Scholar
- Phillips, S.M. et al. (2004). Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br. J. Cancer 91: 469–475.Google Scholar
- Shurin, M.R. et al. (1999). ‘Apoptosis in dendritic cells’ in Dendritic Cells: Biology and Clinical Applications. M.T. Lotze and A.W. Thomson (eds), Academic Press, New York, 673–692.Google Scholar
- Toi, M. (2002). Proinflammation in human tumor microenvironment: its status and implication. Med. Sci. Monit. 8: 25–26.Google Scholar
- Tourkova, I.L. et al. (2004). IL-15 restores MHC class I antigen processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. Submitted.Google Scholar
- Whiteside, T.L. (1993). Tumor Infiltrating Lymphocytes in Human Malignancies. Medical Intelligence Unit, R.G. Landes Co., Austin, TX.Google Scholar
- Whiteside, T.L. et al. (1998). Natural killer cells and tumor therapy. Curr. Topics Microbiol. Immunol. 230: 221–244.Google Scholar
- Whiteside, T.L. et al. (2005). ‘Tumor induced immune suppression and immune escape: Mechanisms and possible solutions’ in: Monitoring T cell Directed Vaccine Trials in Cancer Patients. D. Nagorsen and F. Manincola (eds) in press.Google Scholar